import { EducationalContent } from '../../types';

export const CARDIAC_MONITORS: EducationalContent = {
  id: 'wearables-cardiac-monitors',
  type: 'concept',
  name: 'Cardiac Monitors',
  alternateNames: ['Heart Monitors', 'ECG Monitors', 'Cardiac Rhythm Monitors', 'Heart Rate Monitors', 'Arrhythmia Monitors'],
  levels: {
    1: {
      level: 1,
      summary: 'Cardiac monitors are devices that track your heart rhythm and rate to help detect heart problems like irregular heartbeats.',
      explanation: 'Your heart beats in a regular rhythm, and when that rhythm becomes irregular, it can sometimes cause health problems. Cardiac monitors are devices that watch your heart activity to detect any irregularities. Some cardiac monitors are worn like patches on your chest or small devices on your wrist like a smartwatch. They can record your heart\'s electrical signals, which doctors can then review to see if there are any problems. Some monitors are used for just a few days to catch occasional irregular heartbeats, while others might be worn for weeks or even implanted under the skin for long-term monitoring. Recently, some smartwatches have added features that can detect irregular heart rhythms and alert users. If a problem is detected, doctors can then decide on the best treatment. These devices help catch heart problems early, which can be very important for staying healthy.',
      keyTerms: [
        { term: 'heart rhythm', definition: 'The pattern of your heartbeat, which should be regular' },
        { term: 'irregular heartbeat', definition: 'When your heart beats in an abnormal pattern' },
        { term: 'wearable', definition: 'A device worn on the body to monitor health' },
        { term: 'smartwatch', definition: 'A watch that can track heart rhythm and other health data' },
        { term: 'ECG', definition: 'Electrocardiogram; a recording of your heart electrical signals' },
      ],
    },
    2: {
      level: 2,
      summary: 'Cardiac monitors are wearable or implantable devices that record heart electrical activity or rhythm, used for diagnosing arrhythmias, monitoring cardiac conditions, and screening for atrial fibrillation.',
      explanation: 'Cardiac monitoring devices serve diagnostic, monitoring, and screening purposes for heart rhythm disorders. Traditional Holter monitors record continuous ECG (electrocardiogram) for 24-48 hours, capturing heart electrical activity through electrodes on the chest. Extended monitoring options include event monitors worn for weeks that record when activated by symptoms, and patch monitors (like Zio patch) providing continuous recording for up to 14 days in a convenient adhesive format. Implantable loop recorders are small devices inserted under the skin that monitor for up to 3 years, detecting infrequent arrhythmias. Consumer wearables like Apple Watch and Fitbit now offer FDA-cleared features for passive atrial fibrillation detection using photoplethysmography (PPG, the same light-based technology used for heart rate) and on-demand single-lead ECG recording. These consumer devices have demonstrated reasonable accuracy for atrial fibrillation detection but are screening tools, not diagnostic devices - abnormal findings require clinical confirmation. Key clinical applications include evaluating symptoms like palpitations or fainting, diagnosing atrial fibrillation (which increases stroke risk), and monitoring heart rate control in known cardiac conditions. Detection of atrial fibrillation enables anticoagulation therapy to prevent strokes.',
      keyTerms: [
        { term: 'Holter monitor', definition: 'Device recording continuous ECG for 24-48 hours' },
        { term: 'event monitor', definition: 'Wearable that records heart rhythm when symptoms occur' },
        { term: 'patch monitor', definition: 'Adhesive device providing extended continuous ECG recording' },
        { term: 'implantable loop recorder', definition: 'Small device inserted under skin for long-term monitoring' },
        { term: 'atrial fibrillation', definition: 'Irregular heart rhythm that increases stroke risk' },
        { term: 'photoplethysmography', definition: 'Light-based technology detecting pulse and rhythm' },
        { term: 'single-lead ECG', definition: 'Basic heart electrical recording from consumer wearables' },
        { term: 'anticoagulation', definition: 'Blood-thinning medication to prevent strokes in atrial fibrillation' },
      ],
    },
    3: {
      level: 3,
      summary: 'Cardiac monitoring encompasses clinical-grade ambulatory ECG devices, implantable monitors, and FDA-cleared consumer wearables using PPG algorithms and single-lead ECG for arrhythmia detection and screening.',
      explanation: 'The cardiac monitoring landscape spans professional medical devices and consumer wearables with different capabilities and clinical applications. Clinical ambulatory monitors include 24-48 hour Holter monitors providing continuous multi-lead ECG, external loop recorders for 2-4 week monitoring with automatic and patient-triggered recording, and patch monitors (Zio, SEEQ, Carnation) offering extended continuous recording with improved patient compliance. Implantable cardiac monitors (ICMs, also called insertable cardiac monitors) provide multi-year monitoring for patients with unexplained syncope, cryptogenic stroke, or infrequent symptoms. Mobile cardiac telemetry enables real-time transmission to monitoring centers for high-risk patients. Consumer wearables have evolved to include FDA-cleared PPG-based irregular rhythm notification algorithms that passively monitor for atrial fibrillation signatures, and on-demand single-lead ECG recording enabling rhythm strip acquisition during symptoms. Validation studies show Apple Watch atrial fibrillation detection has moderate positive predictive value, appropriate for screening rather than diagnosis. Clinical integration requires understanding device capabilities and limitations: consumer devices may miss paroxysmal atrial fibrillation, cannot diagnose other arrhythmias, and require clinical confirmation of abnormal findings. The regulatory pathway for consumer cardiac devices includes FDA De Novo classification and 510(k) clearances with specific intended use limitations.',
      keyTerms: [
        { term: 'Holter monitor', definition: 'Continuous multi-lead ECG recording for 24-48 hours' },
        { term: 'external loop recorder', definition: 'Extended monitoring device with automatic and patient-triggered recording' },
        { term: 'patch monitor', definition: 'Adhesive monitors like Zio providing up to 14-day recording' },
        { term: 'implantable cardiac monitor', definition: 'Subcutaneous device for multi-year arrhythmia detection' },
        { term: 'mobile cardiac telemetry', definition: 'Real-time transmission of ECG data to monitoring centers' },
        { term: 'PPG algorithm', definition: 'Software analyzing pulse patterns for atrial fibrillation detection' },
        { term: 'single-lead ECG', definition: 'Consumer wearable feature for rhythm strip acquisition' },
        { term: 'De Novo classification', definition: 'FDA regulatory pathway for novel consumer cardiac devices' },
      ],
    },
    4: {
      level: 4,
      summary: 'Scholarly analysis of cardiac monitoring examines diagnostic yield across monitoring modalities, consumer wearable validation, screening program effectiveness, and implications of ubiquitous rhythm monitoring for clinical practice.',
      explanation: 'Academic examination of cardiac monitoring spans clinical cardiology, health services research, and digital health perspectives. Diagnostic yield research compares arrhythmia detection across monitoring modalities, with studies demonstrating superior detection with longer monitoring duration and appropriate patient selection based on symptom frequency and clinical suspicion. Cryptogenic stroke research has established the value of extended monitoring for detecting atrial fibrillation, with implantable monitors identifying AF in approximately 30% of patients over 3 years compared to 3-4% with conventional monitoring. Consumer wearable validation studies examine sensitivity, specificity, and positive predictive value for atrial fibrillation detection, with prospective studies like Apple Heart Study demonstrating feasibility but also highlighting challenges including low positive predictive value in unselected populations. Health economics analyses evaluate cost-effectiveness of different monitoring strategies, considering device costs, diagnostic yield, and downstream outcomes including stroke prevention through anticoagulation. Screening program effectiveness research examines population-level benefits and risks of widespread AF screening, with ongoing debates about optimal target populations and potential harms including overdiagnosis, anxiety, and unnecessary treatment. Clinical workflow implications address management of consumer device alerts, with emerging guidance on clinical response pathways. Emerging research directions include machine learning algorithms for arrhythmia detection improvement, wearable detection of other cardiac conditions, and integration of consumer device data with clinical systems.',
      keyTerms: [
        { term: 'diagnostic yield', definition: 'Rate of arrhythmia detection with different monitoring approaches' },
        { term: 'cryptogenic stroke', definition: 'Stroke without identified cause, often from undetected atrial fibrillation' },
        { term: 'Apple Heart Study', definition: 'Large study validating consumer smartwatch atrial fibrillation detection' },
        { term: 'positive predictive value', definition: 'Probability that detected abnormalities are true positives' },
        { term: 'screening effectiveness', definition: 'Population-level benefits and risks of widespread monitoring' },
        { term: 'overdiagnosis', definition: 'Detection of conditions that would not cause clinical harm' },
        { term: 'machine learning algorithms', definition: 'AI improving arrhythmia detection accuracy' },
        { term: 'clinical workflow', definition: 'Processes for managing consumer device alerts in practice' },
      ],
    },
    5: {
      level: 5,
      summary: 'Clinical application of cardiac monitoring requires appropriate modality selection, systematic interpretation, patient communication, and evidence-based management of findings from both professional devices and consumer wearables.',
      explanation: 'Effective clinical utilization of cardiac monitoring demands strategic approaches to device selection, interpretation, and management. Modality selection should match monitoring duration to arrhythmia frequency: Holter monitors for daily symptoms, event monitors or patches for weekly symptoms, and implantable monitors for monthly or less frequent events. Clinical context guides monitoring goals: symptom correlation for palpitation evaluation, arrhythmia burden quantification for known conditions, or AF detection for cryptogenic stroke or screening populations. Interpretation protocols should address both automated analysis and expert over-read, recognizing that artifacts and algorithm limitations require clinical judgment. For consumer wearable findings, clinical pathways should address patient communication about device limitations, clinical verification of reported abnormalities, and appropriate follow-up testing when warranted. Incidentally detected atrial fibrillation requires stroke risk assessment (CHA2DS2-VASc scoring), shared decision-making about anticoagulation, and consideration of rate or rhythm control strategies. Patient education should set appropriate expectations about monitoring sensitivity, potential for false positives, and the distinction between screening alerts and confirmed diagnoses. Quality metrics include appropriate utilization rates, diagnostic yield, time to diagnosis, and clinical outcomes including stroke prevention. As consumer device capabilities expand, clinicians must stay current with evidence on device performance and appropriate clinical integration.',
      keyTerms: [
        { term: 'modality selection', definition: 'Choosing appropriate monitoring duration based on symptom frequency' },
        { term: 'symptom correlation', definition: 'Linking patient symptoms with recorded heart rhythm events' },
        { term: 'arrhythmia burden', definition: 'Quantification of time spent in abnormal rhythm' },
        { term: 'clinical pathway', definition: 'Standardized approach to managing consumer device findings' },
        { term: 'CHA2DS2-VASc', definition: 'Scoring system for stroke risk assessment in atrial fibrillation' },
        { term: 'shared decision-making', definition: 'Collaborative discussions about anticoagulation based on risk' },
        { term: 'diagnostic yield', definition: 'Likelihood of detecting clinically significant arrhythmias' },
        { term: 'clinical integration', definition: 'Incorporating consumer device data into cardiology practice' },
      ],
      clinicalNotes: 'Select cardiac monitoring modality based on symptom frequency and clinical question. For infrequent symptoms, consider extended monitoring or implantable devices. When patients present with consumer wearable alerts, explain device limitations and pursue confirmatory testing as appropriate. For confirmed atrial fibrillation, assess stroke risk and discuss anticoagulation based on CHA2DS2-VASc score. Document patient education about device capabilities and limitations. Develop clinic protocols for triaging and responding to consumer device findings.',
    },
  },
  media: [],
  citations: [
    {
      id: 'steinhubl-2018',
      type: 'article',
      title: 'Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial',
      authors: ['Steinhubl SR', 'et al.'],
      source: 'JAMA',
      page: '320(2):146-155',
    },
    {
      id: 'perez-2019',
      type: 'article',
      title: 'Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation',
      authors: ['Perez MV', 'et al.'],
      source: 'N Engl J Med',
      page: '381(20):1909-1917',
    },
    {
      id: 'sanna-2014',
      type: 'article',
      title: 'Cryptogenic stroke and underlying atrial fibrillation',
      authors: ['Sanna T', 'et al.'],
      source: 'N Engl J Med',
      page: '370(26):2478-2486',
    },
    {
      id: 'hindricks-2021',
      type: 'article',
      title: '2020 ESC Guidelines for the diagnosis and management of atrial fibrillation',
      authors: ['Hindricks G', 'et al.'],
      source: 'Eur Heart J',
      page: '42(5):373-498',
    },
  ],
  crossReferences: [
    { targetId: 'remote-patient-monitoring', targetType: 'concept', relationship: 'related', label: 'Remote Patient Monitoring' },
    { targetId: 'continuous-glucose-monitors', targetType: 'concept', relationship: 'related', label: 'Continuous Glucose Monitors' },
    { targetId: 'fitness-tracker-basics', targetType: 'concept', relationship: 'related', label: 'Fitness Tracker Basics' },
    { targetId: 'health-data-privacy', targetType: 'concept', relationship: 'related', label: 'Health Data Privacy' },
  ],
  tags: {
    systems: ['digital-health'],
    topics: ['wearables', 'cardiology', 'arrhythmia', 'medical-devices', 'ECG'],
    keywords: ['cardiac monitors', 'heart monitors', 'atrial fibrillation', 'ECG', 'Holter', 'wearable heart monitor'],
  },
  createdAt: '2025-01-28T00:00:00.000Z',
  updatedAt: '2025-01-28T00:00:00.000Z',
  version: 1,
  status: 'published',
  contributors: ['Biological Self Content Team'],
};
